trial · primary record
Atezolizumab
Advanced Extrapulmonary Neuroendocrine Carcinoma
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 189 |
| Primary completion | 2028-10-01 |
| Primary endpoint | Overall survival |
| Registry ID | NCT05058651 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:11.986Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05058651
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.